Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination
- 28 August 2013
- journal article
- review article
- Published by Elsevier BV in Vaccine
- Vol. 31, D66-D71
- https://doi.org/10.1016/j.vaccine.2012.11.046
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccinesVaccine, 2012
- National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implicationsThe Lancet, 2012
- Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000The Lancet, 2012
- Serotype Distribution and Invasive Potential of Group B Streptococcus Isolates Causing Disease in Infants and Colonizing Maternal-Newborn DyadsPLOS ONE, 2011
- Early Outcomes of Group B Streptococcal Meningitis in the 21st CenturyThe Pediatric Infectious Disease Journal, 2010
- Neonatal meningitis in England and Wales: sequelae at 5 years of ageEuropean Journal of Pediatrics, 2005
- Fatal Maternal β-Hemolytic Group B Streptococcal Meningitis: A Case ReportAmerican Journal of Perinatology, 1998
- Group B streptococci in the milk of lactating mothersZentralblatt für Bakteriologie, Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology, 1987
- Sequelae of early-onset group B hemolytic streptococcal neonatal meningitisThe Journal of Pediatrics, 1985
- Long-term sequelae of group B streptococcal meningitis in infantsThe Journal of Pediatrics, 1985